Oscar Health Inc. (OSCR) Tops Q4 EPS by 9c

Oscar Health Inc. (NYSE: OSCR) reported Q4 EPS of ($1.05), $0.09 better than the analyst estimate of ($1.14). Revenue for the quarter came in at $995 million versus the consensus estimate of $1.18 billion.

For earnings history and earnings-related data on Oscar Health Inc. (OSCR) click here.

You May Also Be Interested In

• Nordson Corp. (NDSN) Tops Q3 EPS by 16c; Offers Guidance
• Beam Global (BEEM) Tops Q2 EPS by 8c
• Target raises full-year sales forecast amid ongoing turnaround drive